ADRA2A Antikörper
Dieser Kaninchen Polyklonal Antikörper erkennt spezifisch ADRA2A in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN2196820
Kurzübersicht für ADRA2A Antikörper (ABIN2196820)
Target
Alle ADRA2A Antikörper anzeigen
ADRA2A
(Alpha-2A Adrenergic Receptor (ADRA2A))
Reaktivität
Human
Wirt
Kaninchen
Klonalität
Polyklonal
Konjugat
Dieser ADRA2A Antikörper ist unkonjugiert
Applikation
Western Blotting (WB)
-
-
Kreuzreaktivität
-
Human, Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
-
Calculated cross reactivity: Hu Mo Rt
-
Produktmerkmale
-
ADRA2A (ADRA2, ADRA2R, ADRAR, Alpha-2AAR, alpha-2AAR subtype C10, Alpha-2A adrenoreceptor, ADRENOCEPTOR, ALPHA-2A, adrenergic, alpha-2A-, receptor, alpha-2A-adrenergic receptor, Alpha-2 adrenergic receptor subtype C10)
-
Aufreinigung
-
Purified by immunoaffinity chromatography.
-
Immunogen
-
A synthetic peptide corresponding to a sequence in the middle region of human ADRA2A, identical to the related mouse and rat sequences.
-
Isotyp
-
IgG
-
-
-
Applikationshinweise
-
Optimal working conditions should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Lyophilized
-
Rekonstitution
-
Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
-
Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Konservierungsmittel
-
Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
-
4 °C,-20 °C
-
Informationen zur Lagerung
-
4°C/-20°C
-
Target
-
ADRA2A
(Alpha-2A Adrenergic Receptor (ADRA2A))
-
Andere Bezeichnung
-
ADRA2A
-
UniProt
-
P08913
-
Pathways
-
EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
-